BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Queen MA, Myers AL, Hall M, Shah SS, Williams DJ, Auger KA, Jerardi KE, Statile AM, Tieder JS. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia. Pediatrics 2014;133:e23-9. [PMID: 24324001 DOI: 10.1542/peds.2013-1773] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Tannous R, Haddad RN, Torbey PH. Management of Community-Acquired Pneumonia in Pediatrics: Adherence to Clinical Guidelines. Front Pediatr 2020;8:302. [PMID: 32637387 DOI: 10.3389/fped.2020.00302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Milner TL, McCulloh R, Koster M, Biondi E, Hill V, Ralston S. Antibiotic Prescribing Patterns Across the Continuum of Care for Children Hospitalized With Community-Acquired Pneumonia. Pediatr Emerg Care 2018;34:e7-e10. [PMID: 26555311 DOI: 10.1097/PEC.0000000000000598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hahn A, Heffren J, Abo A. Improving Evidence Based Care of Community Acquired Pneumonia in Children. Clinical Pediatric Emergency Medicine 2018;19:24-32. [DOI: 10.1016/j.cpem.2018.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Shakeel S, Iffat W, Qamar A, Ghuman F, Yamin R, Ahmad N, Ishaq SM, Gajdács M, Patel I, Jamshed S. Pediatricians' Compliance to the Clinical Management Guidelines for Community-Acquired Pneumonia in Infants and Young Children in Pakistan. Healthcare (Basel) 2021;9:701. [PMID: 34207813 DOI: 10.3390/healthcare9060701] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lavi E, Breuer O. The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia. Curr Infect Dis Rep 2016;18:3. [PMID: 26715113 DOI: 10.1007/s11908-015-0509-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Donà D, Luise D, Da Dalt L, Giaquinto C. Treatment of Community-Acquired Pneumonia: Are All Countries Treating Children in the Same Way? A Literature Review. Int J Pediatr 2017;2017:4239268. [PMID: 29234355 DOI: 10.1155/2017/4239268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Iroh Tam PY, Hanisch BR, O'Connell M. The Impact of Adherence to Pediatric Community-Acquired Pneumonia Guidelines on Clinical Outcomes. Clin Pediatr (Phila) 2015;54:1006-8. [PMID: 25422523 DOI: 10.1177/0009922814559381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Kronman MP, Gerber JS, Newland JG, Hersh AL. Database Research for Pediatric Infectious Diseases. J Pediatric Infect Dis Soc 2015;4:143-50. [PMID: 26407414 DOI: 10.1093/jpids/piv007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Lipsett SC, Hall M, Ambroggio L, Hersh AL, Shah SS, Brogan TV, Gerber JS, Williams DJ, Grijalva CG, Blaschke AJ, Neuman MI. Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia. J Pediatr 2021;229:207-215.e1. [PMID: 33045236 DOI: 10.1016/j.jpeds.2020.10.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li Y, Gao J, Wang Q, Ma X. Efficacy of glucocorticoids, vitamin A and caffeine therapies for neonatal mortality in preterm infants: a network meta-analysis. Oncotarget 2017;8:81167-75. [PMID: 29113376 DOI: 10.18632/oncotarget.20882] [Reference Citation Analysis]
11 Popovsky EY, Florin TA. Community-Acquired Pneumonia in Childhood. Encyclopedia of Respiratory Medicine. Elsevier; 2022. pp. 119-31. [DOI: 10.1016/b978-0-08-102723-3.00013-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Tchou MJ, Schondelmeyer AC, Alvarez F, Holmes AV, Lee V, Lossius MN, O'Callaghan J, Rajbhandari P, Soung PJ, Quinonez R. Choosing Wisely in Pediatric Hospital Medicine: 5 New Recommendations to Improve Value. Hosp Pediatr 2021;11:1179-90. [PMID: 34667087 DOI: 10.1542/hpeds.2021-006037] [Reference Citation Analysis]
13 Albuhairi S, Farhan MA, Alanazi S, Althaqib A, Albeladi K, Alarfaj S, Alhezemy R, Ali MG, Faraz A, Alsudais M, Alolayan A. Antibiotic Prescribing Patterns for Hospitalized children with Community-Acquired Pneumonia in a Secondary Care Center. J Infect Public Health 2021;14:1035-41. [PMID: 34166877 DOI: 10.1016/j.jiph.2021.05.018] [Reference Citation Analysis]
14 Shaw R, Popovsky E, Abo A, Jacobs M, Herrera N, Chamberlain J, Hahn A. Improving antibiotic prescribing in the emergency department for uncomplicated community-acquired pneumonia. World J Emerg Med 2020;11:199-205. [PMID: 33014215 DOI: 10.5847/wjem.j.1920-8642.2020.04.001] [Reference Citation Analysis]
15 Markham JL, Hackman S, Hall M, Burns A, Goldman JL. Inpatient outcomes for children receiving empiric methicillin‐resistant Staphylococcus aureus coverage for complicated pneumonia. Journal of Hospital Medicine. [DOI: 10.1002/jhm.2736] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Williams DJ, Hall M, Gerber JS, Neuman MI, Hersh AL, Brogan TV, Parikh K, Mahant S, Blaschke AJ, Shah SS, Grijalva CG; Pediatric Research in Inpatient Settings Network. Impact of a National Guideline on Antibiotic Selection for Hospitalized Pneumonia. Pediatrics 2017;139:e20163231. [PMID: 28275204 DOI: 10.1542/peds.2016-3231] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
17 Boyd K. Back to the Basics: Community-Acquired Pneumonia in Children. Pediatr Ann 2017;46:e257-61. [PMID: 28697267 DOI: 10.3928/19382359-20170616-01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 McCulloh RJ, Patel K. Recent Developments in Pediatric Community-Acquired Pneumonia. Curr Infect Dis Rep 2016;18:14. [PMID: 26960931 DOI: 10.1007/s11908-016-0521-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
19 Tramper-Stranders GA. Childhood community-acquired pneumonia: A review of etiology- and antimicrobial treatment studies. Paediatr Respir Rev 2018;26:41-8. [PMID: 28844414 DOI: 10.1016/j.prrv.2017.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
20 Handy LK, Bryan M, Gerber JS, Zaoutis T, Feemster KA. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia. Pediatrics 2017;139:e20162331. [PMID: 28270546 DOI: 10.1542/peds.2016-2331] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
21 Le Saux N, Robinson JL; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management. Paediatr Child Health 2015;20:441-50. [PMID: 26744558 DOI: 10.1093/pch/20.8.441] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
22 Manicone PE, Beck J. Quality Improvement and Comparative Effectiveness. Pediatric Clinics of North America 2014;61:693-702. [DOI: 10.1016/j.pcl.2014.04.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Rose MA, Barker M, Liese J, Adams O, Ankermann T, Baumann U, Brinkmann F, Bruns R, Dahlheim M, Ewig S, Forster J, Hofmann G, Kemen C, Lück C, Nadal D, Nüßlein T, Regamey N, Riedler J, Schmidt S, Schwerk N, Seidenberg J, Tenenbaum T, Trapp S, van der Linden M. [Guidelines for the Management of Community Acquired Pneumonia in Children and Adolescents (Pediatric Community Acquired Pneumonia, pCAP) - Issued under the Responsibility of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Pulmonology (GPP)]. Pneumologie 2020;74:515-44. [PMID: 32823360 DOI: 10.1055/a-1139-5132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Wang LA, Cohen-Wolkowiez M, Gonzalez D. Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. Adv Pediatr 2016;63:227-54. [PMID: 27426903 DOI: 10.1016/j.yapd.2016.04.015] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
25 Le Saux NMA, Bowes J, Viel-Thériault I, Thampi N, Blackburn J, Buba M, Harrison MA, Barrowman N. Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016. Paediatr Child Health 2021;26:234-41. [PMID: 34136053 DOI: 10.1093/pch/pxaa066] [Reference Citation Analysis]
26 Moreno-Pérez D, Andrés Martín A, Tagarro García A, Escribano Montaner A, Figuerola Mulet J, García García JJ, Moreno-Galdó A, Rodrigo Gonzalo de Lliria C, Saavedra Lozano J. [Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP)]. An Pediatr (Barc) 2015;83:217.e1-11. [PMID: 25617977 DOI: 10.1016/j.anpedi.2014.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Moreno-pérez D, Andrés Martín A, Tagarro García A, Escribano Montaner A, Figuerola Mulet J, García García J, Moreno-galdó A, Rodrigo Gonzalo de Lliria C, Saavedra Lozano J. Community acquired pneumonia in children: Treatment of complicated cases and risk patients. Consensus statement by the Spanish Society of Paediatric Infectious Diseases (SEIP) and the Spanish Society of Paediatric Chest Diseases (SENP). Anales de Pediatría (English Edition) 2015;83:217.e1-217.e11. [DOI: 10.1016/j.anpede.2015.08.002] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Pernica J, Harman S, Kam A, Bailey J, Carciumaru R, Khan S, Fulford M, Thabane L, Slinger R, Main C, Smieja M, Loeb M. Short-course antimicrobial therapy for paediatric respiratory infections (SAFER): study protocol for a randomized controlled trial. Trials 2018;19:83. [PMID: 29391051 DOI: 10.1186/s13063-018-2457-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 May P, Garrido MM, Cassel JB, Morrison RS, Normand C. Using Length of Stay to Control for Unobserved Heterogeneity When Estimating Treatment Effect on Hospital Costs with Observational Data: Issues of Reliability, Robustness, and Usefulness. Health Serv Res 2016;51:2020-43. [PMID: 26898638 DOI: 10.1111/1475-6773.12460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
30 Nascimento-Carvalho CM, Andrade DC, Vilas-Boas AL. An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence. Expert Opin Pharmacother 2016;17:53-78. [PMID: 26549167 DOI: 10.1517/14656566.2016.1109633] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Thomson J, Ambroggio L, Murtagh Kurowski E, Statile A, Graham C, Courter JD, Sheehan B, Iyer S, White CM, Shah SS. Hospital outcomes associated with guideline-recommended antibiotic therapy for pediatric pneumonia. J Hosp Med 2015;10:13-8. [PMID: 25263758 DOI: 10.1002/jhm.2265] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
32 López-Alcalde J, Rodriguez-Barrientos R, Redondo-Sánchez J, Muñoz-Gutiérrez J, Molero García JM, Rodríguez-Fernández C, Heras-Mosteiro J, Marin-Cañada J, Casanova-Colominas J, Azcoaga-Lorenzo A, Hernandez Santiago V, Gómez-García M. Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database Syst Rev 2018;9:CD009070. [PMID: 30188565 DOI: 10.1002/14651858.CD009070.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Breuer O, Blich O, Cohen-cymberknoh M, Averbuch D, Kharasch S, Shoseyov D, Kerem E. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy: Treatment of Nonresponsive Community-Acquired Pneumonia. Pediatr Pulmonol 2015;50:495-502. [DOI: 10.1002/ppul.23159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]